Scarica l'app Stockscreener
44.20
1.75%
0.76
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
Oppenheimer gives an Outperform recommendation for Vera Therapeutics Inc (VERA) - Knox Daily
Gaining Ground: Vera Therapeutics Inc (VERA) Closes Lower at 43.44, Down -4.86 - The Dwinnex
Vera Therapeutics (NASDAQ:VERA) Trading Up 7% - MarketBeat
Deerfield Management Company L.P. Series C Reduces Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells $1,064,906.25 in Stock - MarketBeat
Vera Therapeutics (NASDAQ:VERA) Shares Down 5.8% - MarketBeat
Marshall Wace LLP Boosts Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics CEO sells over $1 million in company stock - Investing.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Position Boosted by Renaissance Technologies LLC - MarketBeat
Decheng Capital LLC Invests $2.52 Million in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024? - Insider Monkey
Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024? - Yahoo Finance
Nothing is Better Than Vera Therapeutics Inc (VERA) stock at the moment - SETE News
Decheng Capital LLC Invests $2.52 Million in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Point72 DIFC Ltd Has $1.46 Million Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Affinity Asset Advisors LLC Has $13.57 Million Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Ratios Uncovered: Breaking Down Vera Therapeutics Inc (VERA)’s Trailing Twelve Months Metrics - The Dwinnex
VERA overperforms with a 4.82 increase in share price - US Post News
Magnetar Financial LLC Takes $652,000 Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Samlyn Capital LLC - Defense World
First Light Asset Management LLC Acquires 569,590 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
First Light Asset Management LLC Grows Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Examining the Potential Price Growth of Vera Therapeutics Inc (VERA) - Knox Daily
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Integral Health Asset Management LLC - MarketBeat
Adams Street Partners LLC Buys Shares of 13,114 Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
HighVista Strategies LLC Makes New $331,000 Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Cantor Fitzgerald Reiterates Overweight Rating for Vera Therapeutics (NASDAQ:VERA) - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Stake Reduced by Avoro Capital Advisors LLC - Defense World
(VERA) On The My Stocks Page - Stock Traders Daily
American Century Companies Inc. Makes New Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
American Century Companies Inc. Takes Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Insider Selling: Vera Therapeutics, Inc. (NASDAQ:VERA) Director Sells 1,177 Shares of Stock - MarketBeat
Vera Therapeutics director sells over $696k in company stock By Investing.com - Investing.com South Africa
Vera Therapeutics director sells over $696k in company stock By Investing.com - Investing.com Australia
Vera Therapeutics director sells over $696k in company stock By Investing.com - Investing.com Canada
Vera Therapeutics director sells over $696k in company stock - Investing.com
Vera Therapeutics director sells over $696k in company stock By Investing.com - Investing.com UK
Victory Capital Management Inc. Buys 22,560 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Taking a look at what insiders are doing to gauge the Vera Therapeutics Inc (VERA)’s direction - Knox Daily
Vera Therapeutics (NASDAQ:VERA) Stock Rating Upgraded by Evercore ISI - MarketBeat
Vera Therapeutics (NASDAQ:VERA) Lifted to Strong-Buy at Evercore ISI - Defense World
Does Vera Therapeutics Inc (VERA) offer a good opportunity for investors? - SETE News
Arizona State Retirement System Buys 1,250 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Federated Hermes Inc. Buys Shares of 290,000 Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Market Watch Highlights: Vera Therapeutics Inc (VERA) Ends on an Upturn Note at 40.10 - The Dwinnex
Federated Hermes Inc. Acquires Shares of 290,000 Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
A closer look at Vera Therapeutics Inc (VERA) is warranted - US Post News
Vera Therapeutics Inc Inc. (VERA) Price Performance: A Guide to Technical Indicators - The InvestChronicle
Vera Therapeutics (NASDAQ:VERA) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Vera Therapeutics (NASDAQ:VERA) Trading Up 4.3% - MarketBeat
Cantor Fitzgerald Reaffirms "Overweight" Rating for Vera Therapeutics (NASDAQ:VERA) - MarketBeat
Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024 - StockTitan
Vera Therapeutics to Host In-Person R&D Day in New York to - GlobeNewswire
Vera Therapeutics CEO sells shares worth over $585k By Investing.com - Investing.com Australia
Vera Therapeutics CEO sells shares worth over $585k - Investing.com India
Insider Selling: Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells 15,625 Shares of Stock - MarketBeat
Vera Therapeutics CEO sells shares worth over $585k - Investing.com
Vera Therapeutics CEO sells shares worth over $585k By Investing.com - Investing.com UK
Are Vera Therapeutics Inc (VERA) shares a good deal now? - US Post News
Vera Therapeutics Inc’s Shares Reel: -6.16% Quarterly Revenue Decline Amid 1.96B Market Cap - The InvestChronicle
First Turn Management LLC Buys 94,684 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics (NASDAQ:VERA) Trading Down 3.5% - MarketBeat
Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN - GlobeNewswire
Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN - StockTitan
TD Asset Management Inc Raises Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics Inc’s latest rating changes from various analysts - Knox Daily
Market Watch: Vera Therapeutics Inc (VERA)’s Noteworthy Drop, Closing at 37.55 - The Dwinnex
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Candriam S.C.A. Has $10.63 Million Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics' (VERA) Overweight Rating Reiterated at Cantor Fitzgerald - MarketBeat
Vera Therapeutics, Inc. (VERA): Among the Best Mid-Cap Healthcare Stocks To Buy Now - Yahoo Finance
0.05%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):